Chicago Capital Management’s Apogee Therapeutics APGE Stock Holding History

Chicago Capital Management’s Portfolio APGE Stock Details APGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.81M	Buy	+97,100	New	+$8.75M	8.73%	2

Other funds holding APGE

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return

Transmarket Holdings Chicago, Illinois $136M AUM

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

SBI Okasan Asset Management Tokyo, Japan $3.04B AUM

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Mirae Asset Global Investments

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

Chicago Capital Management's APGE Position: Q2 2026 in Review

Chicago Capital Management opened a new position in Apogee Therapeutics (APGE) in Q2 2026: 97,100 shares worth $9.81M. The stake represents 8.73% of the portfolio and ranks #2 among its holdings.

19 funds tracked by Wall St. Rank hold APGE as of Q2 2026.

Chicago Capital Management held 97,100 shares of Apogee Therapeutics worth $9.81M as of Q2 2026.
Apogee Therapeutics was a new Chicago Capital Management position in Q2 2026.
Apogee Therapeutics made up 8.73% of Chicago Capital Management's portfolio in Q2 2026, its #2 holding.
19 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q2 2026.

Based on Chicago Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.